Pulmonary Vascular Disease News

SAN FRANCISCO — In the REAL-PE study of a real-world population of patients with pulmonary embolism, catheter-directed thrombolysis was associated with reduced risk for major bleeding compared with mechanical thrombectomy.

HONOLULU — Patients with chronic thromboembolism pulmonary hypertension and a higher median income had better 6-minute walk distance and hemodynamics than those with a low income, according to a presentation at the CHEST Annual Meeting.

HONOLULU — Patients with pulmonary hypertension who also had diabetes showed increased likelihood for mortality compared with patients without diabetes, according to a systemic review presented at the CHEST Annual Meeting.

HONOLULU — Patients with pulmonary hypertension hospitalized with acute respiratory distress syndrome had increased odds for mortality, extended stays and higher costs, according to research presented at the CHEST Annual Meeting.

HONOLULU — A higher comorbidity burden increases the odds for in-hospital mortality among adults with pulmonary embolism, according to a poster presented at the CHEST Annual Meeting.

The FDA has granted priority review to sotatercept, a novel activin signaling inhibitor designed to treat adults with pulmonary arterial hypertension, according to a manufacturer-issued press release.

Referral to diagnostic imaging decreased with use of an ultrasound protocol in patients with suspected pulmonary embolism, according to a presentation at the European Respiratory Society International Congress.

Local influenza spread was associated with temporary increased CV risk, but flu vaccine dose — high or standard — did not prevent hospitalization for cardiopulmonary events or all-cause death in high-risk patients, researchers reported.

Patients with pulmonary arterial hypertension receiving sotatercept, a novel activin signaling inhibitor, plus background therapy are expected to live longer, according to a European Respiratory Society International Congress presentation.

Use of recreational drugs such as cannabis, opioids, cocaine and amphetamines was prevalent in 11% of patients admitted to French cardiac ICUs and tied to increased odds of in-hospital major adverse events, researchers reported.